TipRanks on MSN
Imricor expands VISABL-AFL clinical trial to UVA Health
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ) has issued an announcement. Imricor Medical Systems has ...
The procedure involves drawing blood, treating it with a laser and ozone, and then reentering it into the body but is not FDA ...
J.J. Watt announced his brother, Steelers linebacker T.J. Watt, underwent surgery for a partially collapsed lung following "a ...
Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.
Kempthorne’s life has been defined by service as mayor of Boise, U.S. senator for Idaho, governor and secretary of the ...
Johnson & Johnson MedTech will be one of several companies set to benefit from a new CMS decision related to pulsed field ...
Zacks Investment Research on MSN
Boston Scientific sustains momentum in the PFA market: What's next?
Atrial fibrillation (AF or AFib) is one of the most common abnormal heart rhythms, affecting nearly 38 million people worldwide — a figure projected to nearly triple by 2030. Boston Scientific BSX ...
Learn more about whether AtriCure, Inc. or Glaukos Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Medtronic plc is rated a Buy, expecting 10-11% annual total returns, supported by 7-8% EPS growth. Learn more about MDT stock ...
So, Field Medical just got a big boost, snagging $35 million in Series B funding. This money is all about pushing forward ...
So, Field Medical just snagged $35 million for their Series B funding round. They’re working on a new way to treat heart ...
Citi Annual Global Healthcare Conference 2025 December 3, 2025 11:15 AM ESTCompany ParticipantsMichael Bodner - Global Head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results